These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 134463)

  • 1. On the proteolytic inhibitory effect of human foetal and neoplastic tissues.
    Fornasari PM; Pandolfi M; Astedt B
    Thromb Res; 1976 Jun; 8(6):829-36. PubMed ID: 134463
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis-inhibitory activity of cultured human cancer cell lines.
    Naito S; Kinjo M; Nanno S; Kohga S; Oka K; Tanaka K
    Gan; 1981 Feb; 72(1):1-7. PubMed ID: 6456167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic inhibitors in human seminal plasma.
    Liedholm P; Astedt B
    Experientia; 1974 Oct; 30(10):1113-4. PubMed ID: 4279828
    [No Abstract]   [Full Text] [Related]  

  • 4. Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.
    Mor A; Maillard J; Favreau C; Reboud-Ravaux M
    Biochim Biophys Acta; 1990 Mar; 1038(1):119-24. PubMed ID: 2138500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based proteinase inhibitors: a critical review.
    Walker B
    Biochem Soc Trans; 1986 Apr; 14(2):397-9. PubMed ID: 2940132
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE; Gow L; Campbell DM; Ogston D
    Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum inhibitors in fibrinolysis.
    Gallimore MJ
    Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
    Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triclosan inhibits tumor necrosis factor-alpha-stimulated urokinase production in human gingival fibroblasts.
    Arancibia R; Cáceres M; Martínez J; Smith PC
    J Periodontal Res; 2009 Dec; 44(6):726-35. PubMed ID: 19874453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors.
    Tamura SY; Weinhouse MI; Roberts CA; Goldman EA; Masukawa K; Anderson SM; Cohen CR; Bradbury AE; Bernardino VT; Dixon SA; Ma MG; Nolan TG; Brunck TK
    Bioorg Med Chem Lett; 2000 May; 10(9):983-7. PubMed ID: 10853674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of protease in the ovarian follicle wall at ovulation (author's transl)].
    Takayama S
    Nihon Naibunpi Gakkai Zasshi; 1979 Jun; 55(6):761-75. PubMed ID: 157294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors and human plasmin: interaction in a whole plasma system.
    Highsmith RF; Weirich CJ; Burnett CJ
    Biochem Biophys Res Commun; 1977 Dec; 79(3):648-56. PubMed ID: 145863
    [No Abstract]   [Full Text] [Related]  

  • 17. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.
    Holmberg L; Lecander I; Persson B; Astedt B
    Biochim Biophys Acta; 1978 Nov; 544(1):128-37. PubMed ID: 152655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase inhibitor in patients with bladder cancer.
    Hisazumi H; Naito K; Misaki T; Kosaka S
    Urol Res; 1974 Dec; 2(3):137-42. PubMed ID: 4446204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthetic inhibitors of serine proteinases. 17. The effect of benzamidine derivatives on the activity of urokinase and the reduction of fibrinolysis].
    Stürzebecher J; Markwardt F
    Pharmazie; 1978 Sep; 33(9):599-602. PubMed ID: 733877
    [No Abstract]   [Full Text] [Related]  

  • 20. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
    Tidwell RR; Geratz JD; Dubovi EJ
    J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.